Nath Bio-Genes Share Price

₹ 133.01

+₹1.13 (0.86%)
1D
Last updated 03 Nov, 2026, 13:07 IST
NSE: NATHBIOGEN
|
Agriculture

Nath Bio-Genes Share Price Today

As of 3 Nov 2026, Nath Bio-Genes share price is ₹133.01. The stock opened at ₹131.90, compared to its previous close of ₹131.88. During today's trading session, Nath Bio-Genes share price moved in the range of ₹131.90 to ₹134.95, with an average price of ₹133.43 for the day. Looking at its last 52-week, the stock has touched a low of ₹126.15 and a high of ₹204.00. On the performance front, Nath Bio-Genes share price has declined by 32.72% over the last six months and is down 24.07% on a year-on-year basis.

Share price over the last 1 day rose from 131.90 to 133.01, ranging between 131.90 and 134.95.

₹131.90
0.86% up today
₹134.95
1D LOW
1D HIGH

Nath Bio-Genes Stock Insights

Latest Earning
Op Profit TrendUp by 1224.50% QoQ
Latest Earning
Net Profit TrendUp by 322700.00% QoQ
Latest Earning
Revenue TrendUp by 512.01% QoQ
Stock Performance
UnderperformingUnderperforming Nifty by 13.37 % in last 1 yr
Shareholding Pattern
FIIFII decreased stake by 29.58%
Nath Bio-Genes stock performance
Open₹131.90
High₹134.95
Low₹131.90
Prev. close₹131.88
Nath Bio-Genes trading activity
Volume1,352
Average traded price₹133.52
Last traded time01:07:27 03 Nov
Last traded quantity3

Circuit
L
H
₹105.51
₹158.25
52-week
L
H
₹126.15
₹204.00
Mkt Cap Cr
249.90

P/E
6.46

P/B
0.37

ROA
3.52%
ROE
5.32%

ROCE
6.87%

Quick Ratio
0.83

EV/EBITDA
4.83

Based on fundamentals, this stock's

Performance: 2 out of 5, Poor
Performance
Poor
Nath Bio-Genes has underperformed the market
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Nath Bio-Genes appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Nath Bio-Genes revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Hindustan Unilever4,37,963.8129.569.1218.18%22.93%27.44%0.9221.35
ITC3,32,847.6016.494.5921.52%28.53%37.26%1.9211.62
Nestle India2,25,612.7855.3239.0528.76%70.58%87.52%0.4235.78
Varun Beverages1,33,642.3652.658.5912.13%15.51%19.85%1.2130.02
Lenskart1,17,959.74173.2413.244.64%5.65%7.0%1.8554.65
Britannia Industries1,11,281.1542.8921.9226.82%49.61%51.85%0.829.46
Marico1,04,113.8453.3524.7319.37%41.85%40.56%1.0438.72
Tata Consumer Products1,01,424.3159.454.595.36%7.69%9.84%1.0331.91
Godrej Consumer Products83,422.3942.316.638.86%15.67%17.34%0.726.22
Dabur India64,926.8333.365.6911.14%16.59%20.18%1.2520.91

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Nath Bio-Genes Company Background

ISIN
INE448G01010
Sector Market Cap
₹ 249.90 Cr

Nath Bio-Genes (India) Limited is an India-based company, which is engaged in the business of production, processing, and marketing of hybrid and GM Seeds. The Company has a product range of field crops, vegetable crops and plant nutrient supplements. The major processing plants are situated at Aurangabad (MS), and Munipalli, Nizamabad (TG). The Company’s product categories include oilseeds and fiber, field crops, vegetables, and plant nutrition. Its fiber and oil seeds include cotton and mustard. The Company's vegetable crop range includes chili, okra, tomato, bottle gourd, bitter gourd, cucumber, coriander, pumpkin, and others. Its field crops include corn, jowar, hybrid paddy, research paddy and wheat. Its plant nutrition products include WINPro GOLii, WINall and Win Chin Win. The Company’s forage products include NUTRIMAX and NUTRIMAX GOLD. It has seed processing facilities and processing plants located in Maharashtra, Telangana, and Andhra Pradesh.

Nath Bio-Genes Financial Highlights

  • Revenue: Nath Bio-Genes reported revenue of ₹452.91 crore in FY26 vs ₹369.46 crore in FY25. It showed an increase of 22.59% on a yearly basis.
  • Operating Profit: Nath Bio-Genes reported an operating profit of ₹46.30 crore in FY26 vs ₹40.04 crore in FY25. It showed an increase of 15.63% on a year-on-year basis.
  • Net Profit: Nath Bio-Genes reported a net profit of ₹41.63 crore in FY26 vs ₹38.60 crore in FY25. It showed an increase of 7.85% on a yearly basis.

Nath Bio-Genes Quarterly Result Highlights

  • Nath Bio-Genes reported revenue of ₹330.30 crore in Jun 2026, compared with ₹53.97 crore in Mar 2026, representing an increase of 512.01% on a quarter-on-quarter (QoQ) basis.
  • Nath Bio-Genes reported an operating profit of ₹32.98 crore in Jun 2026, compared with ₹2.49 crore in Mar 2026, representing an increase of 1,224.50% on a quarter-on-quarter (QoQ) basis.
  • Nath Bio-Genes reported a profit of ₹32.26 crore in Jun 2026, compared with ₹0.01 crore in Mar 2026, reflecting an increase of 3,22,700.00% on a QoQ basis.
  • The earnings per share (EPS) of Nath Bio-Genes stood at ₹20.98 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
45.60%
FII
0.19%
Other DII
0.00%
Retail and other
54.21%
Mutual funds
0.01%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.31%
Mar 20260.23%
Jun 20260.27%
Sep 20260.19%

Nath Bio-Genes Investment Returns

1 day
+0.66%

1 week
+1.27%

1 month
-4.25%

1 year
-24.07%

3 years
-29.31%

5 years
-54.35%

Nath Bio-Genes Share Price History

Nath Bio-Genes share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹131.40 / ₹131.88
+0.66%
30 Oct 26
₹132.05 / ₹131.01
-1.03%
29 Oct 26
₹134.02 / ₹132.38
-0.54%
28 Oct 26
₹133.50 / ₹133.10
-0.24%
Show more

Nath Bio-Genes Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹445.10₹364.91₹332.62₹301.36
Other Income₹7.81₹4.55₹0.63₹0.55
Total Revenue₹452.91₹369.45₹333.25₹301.92
Total Expenses₹412.62₹329.41₹295.14₹265.75
Profit Before Tax₹46.30₹40.58₹41.56₹36.16
Tax₹4.67₹1.98₹1.95₹1.15
Profit After Tax₹41.63₹38.60₹39.62₹35.01
EPS - Basic₹20.98₹20.14₹21.34₹18.43
EPS - Diluted₹20.98₹20.14₹21.34₹18.43

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹46.30₹40.58₹41.56₹36.16
Income before WC changes₹57.53₹53.62₹51.84₹49.10
Change in Assets-₹85.83-₹134.36-₹21.29-₹20.56
Change in Liabilities₹16.66₹99.40₹44.38₹10.75
Change in WC-₹69.17-₹34.95₹23.09-₹9.81
Cash flow from Operations-₹12.57₹17.58₹74.59₹38.37
Cash flow from Investing₹3.46-₹3.96-₹27.40-₹2.88
Cash flow from Financing-₹3.79-₹2.13-₹7.78-₹1.67
Total Cash Flow-₹12.90₹11.49₹39.41₹33.81
Cash (Start of the year)₹88.90₹77.41₹38.00₹4.18
Cash (End of the year)₹76.00₹88.90₹77.41₹38.00

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹318.56₹336.20₹308.57₹271.97
Current Assets₹778.86₹690.01₹571.66₹520.83
Total Assets₹1,097.42₹1,026.21₹880.23₹792.80
Current Liabilities₹394.70₹365.30₹262.45₹216.45
Net Current Asset₹384.17₹324.71₹309.22₹304.38
Non-Current Liabilities₹22.27₹16.52₹7.87₹3.19
Equity Capital₹680.46₹644.39₹609.92₹573.15
Total Equity & Liabilities₹1,097.42₹1,026.21₹880.23₹792.80

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹431.60₹362.31₹332.62₹301.29
Other Income₹7.81₹4.73₹0.65₹0.56
Total Revenue₹439.41₹367.04₹333.28₹301.85
Total Expenses₹396.32₹323.45₹294.60₹265.53
Profit Before Tax₹49.10₹44.12₹42.12₹36.32
Tax₹4.67₹1.98₹1.95₹1.15
Profit After Tax₹44.43₹42.14₹40.18₹35.17
EPS - Basic₹23.42₹22.00₹21.63₹18.51
EPS - Diluted₹23.42₹22.00₹21.63₹18.51

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹49.10₹44.12₹42.12₹36.32
Income before WC changes₹59.46₹56.30₹52.39₹49.25
Change in Assets-₹84.22-₹127.41-₹19.86-₹20.69
Change in Liabilities₹11.77₹99.00₹42.54₹10.72
Change in WC-₹72.45-₹28.41₹22.67-₹9.97
Cash flow from Operations-₹13.91₹26.80₹74.72₹38.37
Cash flow from Investing₹3.46-₹4.05-₹27.40-₹2.88
Cash flow from Financing-₹6.51-₹10.62-₹9.81-₹1.67
Total Cash Flow-₹16.97₹12.13₹37.52₹33.82
Cash (Start of the year)₹87.63₹75.50₹37.98₹4.17
Cash (End of the year)₹70.67₹87.63₹75.50₹37.98

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹318.70₹336.80₹308.57₹271.98
Current Assets₹764.21₹680.55₹568.52₹520.99
Total Assets₹1,082.90₹1,017.35₹877.08₹792.97
Current Liabilities₹388.03₹363.53₹260.60₹216.43
Net Current Asset₹376.17₹317.02₹307.92₹304.56
Non-Current Liabilities₹5.50₹5.15₹5.83₹3.19
Equity Capital₹689.37₹648.67₹610.66₹573.35
Total Equity & Liabilities₹1,082.90₹1,017.35₹877.08₹792.97
* All values are in INR Crore
Nath Bio-Genes market depth
Bid quantityBid priceAsk priceAsk quantity
97133.01133.830
40133133.953
43132.7133.9940
32132.31134351
35132.3134.0520
Total bid quantity247
Total ask quantity444
Nath Bio-Genes technical summary
Bearish indicators2
Neutral indicators6
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
36.27
Neutral

ATR (14)
4.69
Neutral

STOCH(9,6)
47.81
Neutral

STOCH RSI (14)
45.02
Neutral

ADX(9)
27.91
Bearish

UO(9)
38.6
Neutral

ROC(12)
-6.07
Bearish

WillR(14)
-74.49
Neutral
Period
Simple value
Exponential vaue

5D
132.36
131.98

10D
132.13
132.82

20D
134.57
135.34

50D
143.97
142.42

100D
153.36
148.62
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Nath Bio-Genes
Agriculture
Add Stock
Add Another

Nath Bio-Genes Returns Calculator

Ex-date: 11 Sep 2026

Nath Bio-Genes Share Price FAQs












Please be aware that Nath Bio-Genes stock prices are subject to continuous fluctuations due to various factors.